Want to Order Weight-Loss Medicine Directly from the Manufacturer? Eli Lilly Launches a Convenient Solution
In response to the surging demand for weight-loss drugs, pharmaceutical giant Eli Lilly and Co has unveiled LillyDirect, a user-friendly website that allows individuals to order medications directly from the company. This innovative service not only offers access to Eli Lilly's weight-loss medicine Zepbound but also connects individuals with obesity and other health conditions to telehealth companies.
The popularity of potent weight-loss drugs like Novo Nordisk's Wegovy has fueled significant interest in the obesity drug market, which is projected to reach a value of approximately $100 billion by the end of the decade. In light of this, other players in the weight management industry, such as WW International and Ro, have also launched telehealth services for these drugs.
Following the announcement of LillyDirect, shares of WW International (formerly known as WeightWatchers) experienced a sharp decline of over 10%, reflecting the potential impact of Eli Lilly's new website.
Apart from Zepbound, LillyDirect will offer services for patients with diabetes and migraine. The website's pharmacy page will feature various products, including the migraine drug Emgality, insulin, and similar medications, which can be conveniently delivered to patients' homes.
Eli Lilly's direct-to-consumer service aims to connect patients with independent telehealth providers who can support their existing healthcare team or serve as an alternative to in-person care for specific conditions. Additionally, the website will collaborate with third-party providers to offer comprehensive pharmacy services.
BMO Capital Markets analyst Evan Siegerman commended Lilly's proactive approach, stating that the direct-to-consumer model is particularly suitable for obesity medications. He believes that this move will drive the adoption of Zepbound by reducing barriers and facilitating new patient starts.
With Eli Lilly's new offering, ordering weight-loss medication directly from the manufacturer has never been easier. Experience the convenience of LillyDirect and take a step towards achieving your health goals.
2026-10-11
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Medicare’s $50 GLP-1 Door Opens: Weight-Loss Drug Demand Just Got Bigger
-
Weight Loss Expert Reveals Four Foods to Avoid for a Healthier Diet
-
Can IsomorphicLabs Revolutionize Drug Discovery with AlphaFold and AI Partnerships?
-
Eli Lilly Says It Opposes Use of Its Weight-Loss Drug as Beauty Cosmetic
-
Can Eli Lilly's Direct-to-Consumer Model Disrupt the Pharmaceutical Industry?
-
Is Novo Nordisk a Better Investment Than Eli Lilly?
-
The Rise of Muscle-Building Therapies: A Promising Frontier in Biotechnology
-
The Battle for Obesity Drugs: Lilly's Expansion in Germany and the Competition with Novo Nordisk
-
Eli Lilly Collaborates with Redwire Corporation to Explore Drug Manufacturing in Space
-
GLP-1 Weight Loss Drugs: A Review of Current Drugs and Developments
Recommend Reading
-
ContextLogic Acquires gChem for $850 Million in Major Specialty Chemicals Deal
-
$25 Billion Paint Giant Born: AkzoNobel and Axalta Shareholders Approve Merger by Landslide
-
Lenzing Group, a European fiber giant with over a century of history, is being forced to close two plants and cut 2,000 jobs globally
-
Evonik Reports Strong Q2 Results as Supply Chain Disruptions Boost Chemical Margins
-
Ineos Exits Sinopec Tianjin Joint Venture, Pays $120 Million "Breakup Fee"
-
Bivalirudin: Medical Uses, Properties, and Safety
-
Calcium Hypochlorite: Properties, Uses, and Safety
-
July MTBE market price increase in China is significant
-
Business Society Petroleum Coke Daily Review: Overall Downward Trend on August 7, 2026
-
Business Society Melamine Daily Report: Stagnation Warning Issued for August 6, 2026!